Skip to main content
Equibles
ALNY logo

ALNY · Alnylam Pharmaceuticals, Inc.

Track ALNY — free

Use ALNY with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ALNY

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$228.65 +1.53 (+0.67%) At close · Aug 14
Market Cap
$30.51B
Shares
133.81M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.

Funds holding ALNY

759 fund positions
Fund Balance Value % of Fund Open
Growth Fund of America 7,670,994 $2,316,486,768 0.64%
VANGUARD TOTAL STOCK MARKET INDEX FUND 4,215,761 $1,394,868,842 0.07%
AMCAP Fund 4,101,680 $1,238,625,326 1.27%
VANGUARD MID-CAP INDEX FUND 2,864,161 $947,664,950 0.48%
Invesco QQQ Trust, Series 1 2,793,810 $924,387,915 0.25%
JPMorgan Large Cap Growth Fund 2,036,592 $673,847,195 0.63%
Investment Co of America 1,947,787 $644,464,285 0.39%
T. Rowe Price Capital Appreciation Fund 1,715,880 $567,733,216 0.86%
VANGUARD GROWTH INDEX FUND 1,565,234 $517,888,974 0.16%
VANGUARD HEALTH CARE FUND 1,670,679 $517,058,444 1.40%
Fidelity OTC Portfolio 1,593,724 $493,241,641 1.22%
VANGUARD EXTENDED MARKET INDEX FUND 1,480,260 $489,773,626 0.60%
Growth Fund 1,276,486 $422,350,923 0.85%
Dodge & Cox Stock Fund 1,233,200 $408,028,884 0.36%
Fidelity Growth Company Fund 1,338,874 $404,313,171 0.41%
Fidelity Contrafund 1,202,994 $398,034,625 0.25%
T. Rowe Price Mid-Cap Growth Fund, Inc. 1,166,560 $385,979,707 1.71%
New Perspective Fund 1,020,320 $337,593,278 0.22%
VANGUARD MID-CAP GROWTH INDEX FUND 1,008,744 $333,763,127 1.14%
iShares Biotechnology ETF 979,642 $324,134,149 3.99%
Strategic Advisers Fidelity U.S. Total Stock Fund 955,780 $288,626,444 0.12%
iShares Russell Mid-Cap Growth ETF 850,606 $281,440,007 1.51%
JPMorgan Mid Cap Growth Fund 700,981 $231,933,583 2.03%
Ultra Fund 747,000 $231,189,030 0.87%
New Economy Fund 723,459 $218,470,149 0.42%
Fidelity Extended Market Index Fund 684,324 $206,652,162 0.48%
American Funds Fundamental Investors 600,000 $198,522,000 0.13%
Fidelity Advisor Growth Opportunities Fund 635,135 $191,798,067 0.54%
Capital Group Growth ETF 613,330 $185,213,393 0.76%
Fidelity Blue Chip Growth Fund 573,365 $177,450,734 0.19%
T. Rowe Price Health Sciences Fund, Inc. 531,894 $175,987,768 1.62%
Invesco NASDAQ 100 ETF 563,667 $170,216,161 0.18%
iShares Russell 1000 Growth ETF 511,131 $169,117,914 0.15%
VANGUARD U.S. GROWTH FUND 554,294 $167,385,702 0.35%
iShares Russell Mid-Cap ETF 484,627 $160,348,535 0.33%
Select Biotechnology Portfolio 511,683 $154,518,032 2.93%
JPMorgan Growth Advantage Fund 447,815 $148,168,549 0.73%
Fidelity Mid Cap Index Fund 469,553 $145,321,958 0.29%
Select Health Care Portfolio 460,000 $138,910,800 2.40%
Asset Allocation Fund 405,917 $134,305,758 0.51%
Heritage Fund 413,220 $127,887,458 2.38%
Fidelity Advisor New Insights Fund 381,380 $126,187,201 0.54%
JNL/T. Rowe Price Capital Appreciation Fund 380,807 $125,997,612 0.91%
VANGUARD HEALTH CARE INDEX FUND 396,853 $119,841,669 0.63%
Federated Hermes MDT Mid Cap Growth Fund 378,793 $117,232,646 1.84%
Fidelity Growth Company K6 Fund 367,813 $111,072,170 0.40%
Fidelity Advisor Biotechnology Fund 339,486 $105,067,522 5.52%
VIP Contrafund Portfolio 308,886 $102,201,111 0.39%
JPMorgan Nasdaq Equity Premium Income ETF 295,318 $97,711,867 0.29%
Fidelity Series Growth Company Fund 303,631 $91,690,489 0.37%
Showing 1–50 of 759 positions
Key facts CIK 1178670 CUSIP 02043Q107 13F (30d) 739 filings 705 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)